Chaoju Eye Care Holdings Limited
HKEX:2219.HK
2.9 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 338.409 | 338.409 | 346.344 | 346.344 | 228.651 | 228.651 | 266.371 | 266.371 | 248.808 | 248.808 | 250.086 | 250.086 | 237.419 | 237.419 | 159.723 | 159.723 |
Cost of Revenue
| 189.303 | 189.303 | 184.883 | 184.883 | 133.47 | 133.47 | 144.203 | 144.203 | 138.146 | 138.146 | 136.411 | 136.411 | 129.711 | 129.711 | 92.671 | 92.671 |
Gross Profit
| 149.106 | 149.106 | 161.461 | 161.461 | 95.181 | 95.181 | 122.168 | 122.168 | 110.662 | 110.662 | 113.675 | 113.675 | 107.708 | 107.708 | 67.052 | 67.052 |
Gross Profit Ratio
| 0.441 | 0.441 | 0.466 | 0.466 | 0.416 | 0.416 | 0.459 | 0.459 | 0.445 | 0.445 | 0.455 | 0.455 | 0.454 | 0.454 | 0.42 | 0.42 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 55.937 | 55.937 | 55.293 | 55.293 | 34.677 | 34.677 | 46.344 | 46.344 | 39.895 | 39.895 | 37.495 | 37.495 | 39.102 | 39.102 | 27.662 | 27.662 |
Selling & Marketing Expenses
| 26.862 | 26.862 | 25.633 | 25.633 | 17.513 | 17.513 | 13.129 | 13.129 | 13.378 | 13.378 | 10.197 | 10.197 | 9.432 | 9.432 | 7.015 | 7.015 |
SG&A
| 84.177 | 84.177 | 81.609 | 81.609 | 50.993 | 50.993 | 60.358 | 60.358 | 55.375 | 55.375 | 48.876 | 48.876 | 48.308 | 48.308 | 35.876 | 35.876 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 109.161 | 109.161 | 66.327 | 66.327 | 49.567 | 49.567 | 53.751 | 53.751 | 59.504 | 59.504 | 58.434 | 58.434 | 52.592 | 52.592 | 39.282 | 39.282 |
Operating Income
| 64.93 | 64.93 | 79.852 | 79.852 | 44.188 | 44.188 | 61.811 | 61.811 | 55.287 | 55.287 | 64.799 | 64.799 | 59.4 | 59.4 | 31.177 | 31.177 |
Operating Income Ratio
| 0.192 | 0.192 | 0.231 | 0.231 | 0.193 | 0.193 | 0.232 | 0.232 | 0.222 | 0.222 | 0.259 | 0.259 | 0.25 | 0.25 | 0.195 | 0.195 |
Total Other Income Expenses Net
| -7.592 | -7.592 | 12.431 | 12.431 | 9.776 | 9.776 | 3.795 | 3.795 | -3.002 | -3.002 | -11.794 | -11.794 | -4.919 | -4.919 | -6.848 | -6.848 |
Income Before Tax
| 57.338 | 57.338 | 92.283 | 92.283 | 53.964 | 53.964 | 65.606 | 65.606 | 52.286 | 52.286 | 53.006 | 53.006 | 54.482 | 54.482 | 24.329 | 24.329 |
Income Before Tax Ratio
| 0.169 | 0.169 | 0.266 | 0.266 | 0.236 | 0.236 | 0.246 | 0.246 | 0.21 | 0.21 | 0.212 | 0.212 | 0.229 | 0.229 | 0.152 | 0.152 |
Income Tax Expense
| 20.427 | 20.427 | 18.827 | 18.827 | 13.246 | 13.246 | 14.725 | 14.725 | 12.801 | 12.801 | 13.67 | 13.67 | 13.403 | 13.403 | 5.143 | 5.143 |
Net Income
| 39.151 | 39.151 | 75.307 | 75.307 | 42.077 | 42.077 | 51.799 | 51.799 | 40.405 | 40.405 | 40.47 | 40.47 | 41.28 | 41.28 | 20.79 | 20.79 |
Net Income Ratio
| 0.116 | 0.116 | 0.217 | 0.217 | 0.184 | 0.184 | 0.194 | 0.194 | 0.162 | 0.162 | 0.162 | 0.162 | 0.174 | 0.174 | 0.13 | 0.13 |
EPS
| 0.057 | 0.057 | 0.11 | 0.11 | 0.06 | 0.06 | 0.073 | 0.073 | 0.058 | 0.058 | 0.074 | 0.074 | 0.073 | 0.073 | 0.038 | 0.038 |
EPS Diluted
| 0.057 | 0.057 | 0.11 | 0.11 | 0.06 | 0.06 | 0.073 | 0.073 | 0.058 | 0.058 | 0.074 | 0.074 | 0.075 | 0.075 | 0.038 | 0.038 |
EBITDA
| 83.578 | 83.578 | 97.418 | 97.418 | 59.084 | 59.084 | 74.849 | 74.849 | 66.828 | 66.828 | 76.575 | 76.575 | 70.139 | 70.139 | 42.451 | 42.451 |
EBITDA Ratio
| 0.247 | 0.247 | 0.281 | 0.281 | 0.258 | 0.258 | 0.281 | 0.281 | 0.269 | 0.269 | 0.306 | 0.306 | 0.295 | 0.295 | 0.266 | 0.266 |